Strict vegans/vegetarians with low intake who prefer a rapid correctionthough high-dose oral B12 is usually effective (AAFP)
On 24 November 2025, Novo Nordisk reported that oral semaglutide had failed to slow Alzheimers disease in the EVOKE and EVOKE+ trials, which together enrolled 3,808 participants and stand as the largest evaluation of this drug class in any neurodegenerative condition [1]
Regular TSH monitoring prevents this issue, and your provider can fine-tune your thyroid dose based on lab results
Access the full executive-grade market analysis here: Click the link and fill out the form to receive a tailored executive summary, competitive benchmarking, and custom growth insights for your organization
Most patients achieve target weight loss within 6-12 months of starting treatment
The interactions between Ozempic and eating disorders are complex